141 related articles for article (PubMed ID: 3571185)
21. Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis.
Simard JR; Zunszain PA; Hamilton JA; Curry S
J Mol Biol; 2006 Aug; 361(2):336-51. PubMed ID: 16844140
[TBL] [Abstract][Full Text] [Related]
22. Molecular dynamics study of conformational changes in human serum albumin by binding of fatty acids.
Fujiwara S; Amisaki T
Proteins; 2006 Aug; 64(3):730-9. PubMed ID: 16783783
[TBL] [Abstract][Full Text] [Related]
23. Binding of suprofen to human serum albumin. Role of the suprofen carboxyl group.
Maruyama T; Lin CC; Yamasaki K; Miyoshi T; Imai T; Yamasaki M; Otagiri M
Biochem Pharmacol; 1993 Mar; 45(5):1017-26. PubMed ID: 8461031
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and spectroscopic studies of resveratrol aliphatic acid ligands of human serum albumin.
Jiang YL
Bioorg Med Chem; 2008 Jun; 16(12):6406-14. PubMed ID: 18499462
[TBL] [Abstract][Full Text] [Related]
25. Chromatographic analysis of the effects of fatty acids and glycation on binding by probes for Sudlow sites I and II to human serum albumin.
Anguizola J; Debolt E; Suresh D; Hage DS
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 May; 1021():175-181. PubMed ID: 26468085
[TBL] [Abstract][Full Text] [Related]
26. Spectroscopic analysis of the impact of oxidative stress on the structure of human serum albumin (HSA) in terms of its binding properties.
Maciążek-Jurczyk M; Sułkowska A
Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 136 Pt B():265-82. PubMed ID: 25448930
[TBL] [Abstract][Full Text] [Related]
27. Interaction of lafutidine in binding to human serum albumin in gastric ulcer therapy: STD-NMR, WaterLOGSY-NMR, NMR relaxation times, Tr-NOESY, molecule docking, and spectroscopic studies.
Yang H; Huang Y; He J; Li S; Tang B; Li H
Arch Biochem Biophys; 2016 Sep; 606():81-9. PubMed ID: 27457418
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of the binding of oxovanadium(IV) to human serum albumin.
Correia I; Jakusch T; Cobbinna E; Mehtab S; Tomaz I; Nagy NV; Rockenbauer A; Pessoa JC; Kiss T
Dalton Trans; 2012 Jun; 41(21):6477-87. PubMed ID: 22476413
[TBL] [Abstract][Full Text] [Related]
29. Correspondence of fatty acid and drug binding sites on human serum albumin: a two-dimensional nuclear magnetic resonance study.
Krenzel ES; Chen Z; Hamilton JA
Biochemistry; 2013 Mar; 52(9):1559-67. PubMed ID: 23360066
[TBL] [Abstract][Full Text] [Related]
30. Utilization of long-chain free fatty acids by human platelets.
Spector AA; Hoak JC; Warner ED; Fry GL
J Clin Invest; 1970 Aug; 49(8):1489-96. PubMed ID: 5431660
[TBL] [Abstract][Full Text] [Related]
31. Allosteric Sensing of Fatty Acid Binding by NMR: Application to Human Serum Albumin.
Jafari N; Ahmed R; Gloyd M; Bloomfield J; Britz-McKibbin P; Melacini G
J Med Chem; 2016 Aug; 59(16):7457-65. PubMed ID: 27429126
[TBL] [Abstract][Full Text] [Related]
32. Comparative phosphorescence and optically detected magnetic resonance studies of fatty acid binding to serum albumin.
Mao SY; Maki AH
Biochemistry; 1987 Jun; 26(12):3576-82. PubMed ID: 3651398
[TBL] [Abstract][Full Text] [Related]
33. Effect of free fatty acids on the concentration of free thyroxine in human serum: the role of albumin.
Mendel CM; Frost PH; Cavalieri RR
J Clin Endocrinol Metab; 1986 Dec; 63(6):1394-9. PubMed ID: 3782424
[TBL] [Abstract][Full Text] [Related]
34. (19)F NMR spectroscopic characterization of the interaction of niflumic acid with human serum albumin.
Kitamura K; Omran AA; Takegami S; Tanaka R; Kitade T
Anal Bioanal Chem; 2007 Apr; 387(8):2843-8. PubMed ID: 17377783
[TBL] [Abstract][Full Text] [Related]
35. 19F NMR spectroscopic study on the binding of triflupromazine to bovine and human serum albumins.
Kitamura K; Kume M; Yamamoto M; Takegami S; Kitade T
J Pharm Biomed Anal; 2004 Oct; 36(2):411-4. PubMed ID: 15496337
[TBL] [Abstract][Full Text] [Related]
36. NMR metabolomics profiling of blood plasma mimics shows that medium- and long-chain fatty acids differently release metabolites from human serum albumin.
Jupin M; Michiels PJ; Girard FC; Spraul M; Wijmenga SS
J Magn Reson; 2014 Feb; 239():34-43. PubMed ID: 24374750
[TBL] [Abstract][Full Text] [Related]
37. Determining molecular binding sites on human serum albumin by displacement of oleic acid.
Sarver RW; Gao H; Tian F
Anal Biochem; 2005 Dec; 347(2):297-302. PubMed ID: 16289007
[TBL] [Abstract][Full Text] [Related]
38. A spectroscopic study of the interaction of isoflavones with human serum albumin.
Mahesha HG; Singh SA; Srinivasan N; Rao AG
FEBS J; 2006 Feb; 273(3):451-67. PubMed ID: 16420470
[TBL] [Abstract][Full Text] [Related]
39. Thyroid hormone-free albumin: charcoal treatment or resin treatment.
Tanaka K; Matsumoto Y; Mochizuki M; Takezawa M; Yoshimura M; Motomura T; Fukuda F; Nakao K
Ann Nucl Med; 1996 Aug; 10(3):357-9. PubMed ID: 8883716
[TBL] [Abstract][Full Text] [Related]
40. NMR identification of endogenous metabolites interacting with fatted and non-fatted human serum albumin in blood plasma: Fatty acids influence the HSA-metabolite interaction.
Jupin M; Michiels PJ; Girard FC; Spraul M; Wijmenga SS
J Magn Reson; 2013 Mar; 228():81-94. PubMed ID: 23357430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
